Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2007; 13(30): 4072-4079
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4072
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4072
Figure 1 Mean log10 changes in serum hepatitis B virus (HBV) DNA levels after administration of lamivudine (dashed line) and adefovir (continuous line).
Mean (± SD) changes from baseline in serum HBV DNA concentrations were evaluated using real time PCR assays (lower limit of detection, 366 copies/mL). aP < 0.05. HBV: hepatitis B virus; LMV: lamivudine; ADV: adefovir dipivoxil.
- Citation: Seo YS, Kim JH, Yeon JE, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH. Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance. World J Gastroenterol 2007; 13(30): 4072-4079
- URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4072.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i30.4072